Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Debt to Equity (2016 - 2024)

Historic Debt to Equity for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q1 2024 value amounting to $0.68.

  • Prestige Consumer Healthcare's Debt to Equity fell 2685.92% to $0.68 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.68, marking a year-over-year decrease of 2685.92%. This contributed to the annual value of $0.68 for FY2024, which is 2685.92% down from last year.
  • Prestige Consumer Healthcare's Debt to Equity amounted to $0.68 in Q1 2024, which was down 2685.92% from $0.93 recorded in Q1 2023.
  • In the past 5 years, Prestige Consumer Healthcare's Debt to Equity registered a high of $1.48 during Q1 2020, and its lowest value of $0.0 during Q3 2021.
  • Moreover, its 5-year median value for Debt to Equity was $1.09 (2021), whereas its average is $0.99.
  • In the last 5 years, Prestige Consumer Healthcare's Debt to Equity plummeted by 9966.11% in 2021 and then tumbled by 64.2% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Debt to Equity (Quarter) stood at $1.17 in 2020, then plummeted by 99.65% to $0.0 in 2021, then surged by 22701.91% to $0.94 in 2022, then decreased by 0.64% to $0.93 in 2023, then dropped by 26.86% to $0.68 in 2024.
  • Its Debt to Equity stands at $0.68 for Q1 2024, versus $0.93 for Q1 2023 and $0.94 for Q1 2022.